We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DDMAC Promotion Review Times Are Too Slow, Drugmakers Say
DDMAC Promotion Review Times Are Too Slow, Drugmakers Say
May 21, 2010
Despite an increasing enforcement presence through warning and untitled letters, the FDA’s Division of Drug Marketing, Advertising and Communications’ (DDMAC) review times for pre-submitted direct-to-consumer (DTC) advertisements continue to lag.